In summary, our study indicates that 2R/2R and 2R/1R were significantly associated with increased risk, and 1R/1R and 1R/0R were significantly associated with the decreased risk of BRCA1+ breast cancer, whereas 2R/1R was significantly associated with the increased risk of BRCA2+ breast cancer. The gene discussed is BRCA2; the disease is breast carcinoma.